These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16331772)

  • 1. Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis.
    Silverman SL; Piziak VK; Chen P; Misurski DA; Wagman RB
    J Rheumatol; 2005 Dec; 32(12):2405-9. PubMed ID: 16331772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatide.
    Crans GG; Silverman SL; Genant HK; Glass EV; Krege JH
    Arthritis Rheum; 2004 Dec; 50(12):4028-34. PubMed ID: 15593198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.
    Oglesby AK; Minshall ME; Shen W; Xie S; Silverman SL
    J Rheumatol; 2003 Jul; 30(7):1579-83. PubMed ID: 12858462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of recent fracture on health-related quality of life in postmenopausal women.
    Brenneman SK; Barrett-Connor E; Sajjan S; Markson LE; Siris ES
    J Bone Miner Res; 2006 Jun; 21(6):809-16. PubMed ID: 16753011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly--a 12- and 22-year follow-up of 257 patients.
    Hasserius R; Karlsson MK; Jónsson B; Redlund-Johnell I; Johnell O
    Calcif Tissue Int; 2005 Apr; 76(4):235-42. PubMed ID: 15812579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring quality of life in women with osteoporosis. Osteoporosis Quality of Life Study Group.
    Osteoporos Int; 1997; 7(5):478-87. PubMed ID: 9425507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-year results from the EFOS study.
    Karras D; Stoykov I; Lems WF; Langdahl BL; Ljunggren Ö; Barrett A; Walsh JB; Fahrleitner-Pammer A; Rajzbaum G; Jakob F; Marin F
    J Rheumatol; 2012 Mar; 39(3):600-9. PubMed ID: 22247365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.
    Oleksik A; Lips P; Dawson A; Minshall ME; Shen W; Cooper C; Kanis J
    J Bone Miner Res; 2000 Jul; 15(7):1384-92. PubMed ID: 10893688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of strontium ranelate on spinal osteoarthritis progression.
    Bruyere O; Delferriere D; Roux C; Wark JD; Spector T; Devogelaer JP; Brixen K; Adami S; Fechtenbaum J; Kolta S; Reginster JY
    Ann Rheum Dis; 2008 Mar; 67(3):335-9. PubMed ID: 17965119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and perceived menopausal symptoms: factors influencing low back pain in postmenopausal women.
    Ahn S; Song R
    J Adv Nurs; 2009 Jun; 65(6):1228-36. PubMed ID: 19374677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.
    Miller PD; Shergy WJ; Body JJ; Chen P; Rohe ME; Krege JH
    J Rheumatol; 2005 Aug; 32(8):1556-62. PubMed ID: 16078334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS.
    Lyritis G; Marin F; Barker C; Pfeifer M; Farrerons J; Brixen K; del Pino J; Keen R; Nickelsen TN;
    Curr Med Res Opin; 2010 Aug; 26(8):1799-807. PubMed ID: 20482322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of musculoskeletal pain in Chinese elderly and the impact on 4-year physical function and quality of life.
    Woo J; Leung J; Lau E
    Public Health; 2009 Aug; 123(8):549-56. PubMed ID: 19709699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT.
    Sambrook PN; Silverman SL; Cauley JA; Recknor C; Olson M; Su G; Boonen S; Black D; Adachi JD;
    Bone; 2011 Jun; 48(6):1298-304. PubMed ID: 21421092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled trial of the effects of physical exercises and estrogen therapy on health-related quality of life in postmenopausal women.
    Moriyama CK; Oneda B; Bernardo FR; Cardoso CG; Forjaz CL; Abrahao SB; Mion D; Fonseca AM; Tinucci T
    Menopause; 2008; 15(4 Pt 1):613-8. PubMed ID: 18551087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis.
    Ringe JD; Faber H; Bock O; Valentine S; Felsenberg D; Pfeifer M; Minne HW; Schwalen S
    Rheumatol Int; 2002 Sep; 22(5):199-203. PubMed ID: 12215866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of back pain frequency with mortality, coronary heart events, mobility, and quality of life in elderly women.
    Zhu K; Devine A; Dick IM; Prince RL
    Spine (Phila Pa 1976); 2007 Aug; 32(18):2012-8. PubMed ID: 17700450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.